AMETEK, Inc. has recently released its 10-Q report, providing a detailed insight into the company's recent financial performance and operations. AMETEK, Inc. manufactures and sells electronic instruments and electromechanical devices in the United States and internationally. The company's electronic instruments segment offers advanced instruments for various industries, while the electromechanical segment provides medical components, automation solutions, and thermal management systems.
In the recent report, AMETEK, Inc. highlighted the impact of the United States government's announcement of additional tariffs and trade restrictions on imported goods. This has led to uncertainties in the market, potentially affecting demand for products, costs, and the global economy, particularly in China. The company emphasized its proactive monitoring and analysis of the situation and plans to implement necessary actions to mitigate the effects.
The report also detailed the financial results for the first quarter of 2025. AMETEK, Inc. reported net sales of $1,732.0 million, a decrease of 0.2% compared to the first quarter of 2024. International sales accounted for 46.4% of net sales, with a decrease primarily driven by lower demand in Europe and Asia. However, the company saw a significant increase in orders, totaling $1,797.8 million, representing an 8.1% rise from the first quarter of 2024. The backlog of unfilled orders also increased to $3,469.1 million.
Cost of sales decreased to $1,107.0 million, representing 63.9% of net sales, while segment operating income increased to $482.8 million, with operating margins at 27.9% for the first quarter of 2025. The company's diluted earnings per share for the first quarter of 2025 were reported at $1.52, showing an increase of 13.4% from the same period in 2024.
In terms of financial condition, AMETEK, Inc. reported cash provided by operating activities of $417.5 million for the first three months of 2025, an increase of 1.8% compared to the same period in 2024. The company's free cash flow and EBITDA for the first three months of 2025 were $394.5 million and $558.5 million, respectively. Cash used by investing activities totaled $125.7 million, primarily due to the acquisition of Kern Microtechnik.
AMETEK, Inc. also detailed its liquidity and capital resources, reporting a total debt, net of $1,931.0 million at March 31, 2025, with available borrowing capacity of $2,207.1 million under its revolving credit facility. The company's debt-to-capital ratio was 16.2% at March 31, 2025, compared to 17.7% at December 31, 2024, indicating a favorable financial position.
The report also addressed the company's critical accounting policies and forward-looking information, emphasizing the factors and uncertainties that may affect actual results. AMETEK, Inc. highlighted its compliance with all covenants and its belief in having sufficient cash-generating capabilities to meet operating needs and contractual obligations in the foreseeable future. As a result of these announcements, the company's shares have moved -0.8% on the market, and are now trading at a price of $168.2. For the full picture, make sure to review AMETEK's 10-Q report.
